相关实验视频

Updated: Jan 17, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

局部使用的环氧德克斯米诺环素综合物抑制了与白炎相关的干眼疾病的炎症

Jingfan Li¹, Haohao Cui¹, Xue Sun¹

¹Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Provincial Hospital Clinical Medical College of Zhengzhou University, 450003 Zhengzhou, China.

International immunopharmacology

|September 13, 2025

概括

一种新的局部循环德克斯-米诺环复合物 (CCH/MI) 有效治疗与白炎相关的干眼疾病 (BRDED). 这种治疗减少了炎症并恢复了眼睛表面的健康,没有毒性,为口服米诺环素提供了更安全的替代品.

科学领域:

眼科医生眼科眼科
药理学药理学是指药理学的学科.
生物材料科学生物材料科学

背景情况:

与白炎相关的干眼病 (BRDED) 涉及眼边缘炎症和眼睛表面损伤.
口服米诺环素 (MI) 是有效的,但有系统性的副作用;局部MI面临溶解性和稳定性的挑战.
为预防视力丧失,开发安全有效的局部治疗方法对BRDED至关重要.

研究的目的:

评估局部循环德克斯特林-米诺环素包容复合物 (CCH/MI) 对BRDED的治疗效果.
研究BRDED中CCH/MI的潜在抗炎机制.
评估CCH/MI作为BRDED潜在治疗的安全性和有效性.

主要方法:

一个循环德克斯特林-米诺环素含有复合物的配方 (CCH/MI).
使用人类角膜上皮细胞 (HCE-2) 和细胞毒性试验 (CCK-8) 对抗炎症作用的体外评估.
在子BRDED模型中的体内评估,测量眼产量,角膜染色,膜稳定性和细胞亡 (TUNEL).

主要成果:

CCH/MI没有显示对眼细胞的细胞毒性 (HCE-2,CCL-20.2).
在体外和体内,CCH/MI显著降低了关键炎症标志物的表达 (NF-κB,p38 MAPK,MMP-9,TNF-α,iNOS).
在子中,CCH/MI改善了眼的产生,减少了角膜损伤,增强了膜的稳定性,并减少了亡.

结论:

局部CCH / MI表现出强大的抗炎性质,并促进BRDED中的眼表平衡.
CCH/MI是BRDED的安全有效治疗策略,克服了口服和常规局部米诺环林的局限性.
这种新型配方为患有白炎相关的干眼疾病的患者提供了有前途的治疗选择.

关键词:

血炎是什么? 血炎是什么?循环德克斯特林 (Cyclodextrin) 是一种循环德克斯特林.干眼疾病是干眼的疾病.敏诺环素的使用方法眼睛表面的平衡是眼睛表面的平衡.

更多相关视频

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction

Published on: April 1, 2019

In Vivo Confocal Microscopy in the Diagnosis and Management of Dry Eye: A Focus on Imaging Protocols and Interpretation

In Vivo Confocal Microscopy in the Diagnosis and Management of Dry Eye: A Focus on Imaging Protocols and Interpretation

Published on: November 11, 2025

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...